Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T0RV
|
|||
Drug Name |
PMID28048944-Compound-11
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
AMAKEM NV
|
|||
Structure |
Download2D MOL |
|||
Formula |
C30H25FN4O4S
|
|||
Canonical SMILES |
C1COC(=O)C1SC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)C4=C(C=CC(=C4)C(=O)NC5=C(C=NC=C5)F)CN
|
|||
InChI |
1S/C30H25FN4O4S/c31-25-17-33-12-10-26(25)35-29(37)20-4-5-21(16-32)24(15-20)19-2-1-3-22(14-19)34-28(36)18-6-8-23(9-7-18)40-27-11-13-39-30(27)38/h1-10,12,14-15,17,27H,11,13,16,32H2,(H,34,36)(H,33,35,37)
|
|||
InChIKey |
QKLHHIYLYLZRFM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Rho kinase inhibitors: a patent review (2014 - 2016).Expert Opin Ther Pat. 2017 Apr;27(4):507-515. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.